Streetbeat News

Stock Prices

EFSC

Enterprise Financial Services (NASDAQ:EFSC) reported Q3 2024 earnings per share of $1.29, surpassing the analyst estimate of $1.14. The company's sales were $164.889 million, exceeding the expected $158.470 million and marking a 7.26% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:09 pm

WASH

Washington Trust Bancorp reported Q3 2024 earnings per share of $0.64, surpassing the analyst estimate of $0.56. Sales were $32.262 million, also beating the estimate of $31.628 million. Despite beating estimates, both EPS and sales showed a decline compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:09 pm

RVMD

Revolution Medicines has dosed the first patient in a Phase 3 study of RMC-6236 for previously treated metastatic pancreatic ductal adenocarcinoma. This marks a significant milestone in the development of their cancer treatment pipeline.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:06 pm

XGN

Exagen Inc. announced that five of its abstracts have been accepted for presentation at the 2024 American College of Rheumatology Convergence. This highlights the company's ongoing research and development efforts in the field of rheumatology.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:05 pm

GLD

JDST

JNUG

Unusual options activity has been observed in the SPDR Gold Trust (GLD), with a bearish sentiment despite its recent gains. This has implications for Direxion's leveraged ETFs, JNUG and JDST, which are designed for short-term exposure to gold market movements. JNUG has performed well, while JDST has struggled.

Portfolio Pulse from Joshenomoto@benzinga.com

October 21, 2024 | 8:04 pm

CHGG

In the past three months, analysts have shown a range of opinions on Chegg (NYSE:CHGG), with most being indifferent. Recent analyst actions have lowered price targets, reflecting a negative outlook. Chegg's financial performance shows challenges with declining revenue, negative margins, and high debt levels.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:01 pm

STM

STMicroelectronics (NYSE:STM) has received mixed analyst ratings, with recent downgrades in price targets. The average 12-month price target is now $39.5, a 19.8% decrease from the previous $49.25. Analysts have lowered their ratings due to revenue challenges and a decline in growth, despite strong net margins and efficient asset use.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:01 pm

WRBY

Warby Parker (NYSE:WRBY) has been analyzed by six analysts, showing a range of ratings from bullish to indifferent. The average 12-month price target has increased by 8.48% to $18.17. Warby Parker has shown a 13.32% revenue growth rate, but faces challenges with a net margin of -3.59% and ROA of -1.12%.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:01 pm

WRBY

Warby Parker (NYSE:WRBY) has received mixed ratings from analysts, with a recent increase in average price targets. Analysts have shown a mix of bullish and somewhat bullish sentiments, with a notable increase in the average price target to $18.17. The company's financials show strong revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:01 pm

TXN

Texas Instruments (NASDAQ:TXN) is set to announce its quarterly earnings on October 22, 2024. Analysts expect an EPS of $1.37. Investors are hopeful for results that surpass estimates and positive future guidance. Historically, TXN's stock price has been influenced by earnings results and projections.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:01 pm